Breaking new ground: The potential of antibody drug conjugates in the treatment of cancer

Here, Steve Lyon, digital lead, Communities & Content, Allied Market Research (AMR), discusses some examples of new technology in the ADC space and the ground-breaking potential this new class of drugs will have in the treatment of cancer